Hims & Hers (HIMS) is down -8.0%, or -$4.65 to $53.35.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Hinge Health (HNGE) Prices IPO at $32 a Share Amid Strong Demand from Investors
- Evernorth weight loss drug price point attractive compared to Hims, says Truist
- Citi says Evernorth plan ‘slight headwind’ to Hims & Hers
- Hims & Hers shares down 11% to $51.33 after Evernorth weight loss plan
- Cigna’s Evernorth caps monthly weight loss drug cost at $200